Beckman Coulter, Inc.
RA Capital Advisors was engaged by Beckman Industries, Inc. (formerly NYSE:BEC) to assist in resolving certain shareholder matters that were potentially distracting to the company’s operations. In addition, RA Capital Advisors assisted in developing a strategic plan to improve operations and corporate governance. Following, RA Capital Advisors represented Beckman in its $1.05 billion acquisition of Coulter Corporation. The combined company is a market leader in diagnostics systems that automate biomedical testing and serves hospital laboratories, pharmaceutical and biotechnology companies, universities, medical schools, and research institutions worldwide.
